Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleio Ampelakiotou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomolecules|May 4, 2026
The Complement System in the Setting of Critical Illness-A Narrative ReviewKleio Ampelakiotou, Ioanna Nikitopoulou, Stelios Kokkoris, et al.
Biomedicines|August 29, 2024
Erythropoietin Effect on Complement Activation in Chronic Kidney DiseaseVirginia Athanasiadou, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Virology|February 7, 2021
A novel ratio of CD8<sup>+</sup>:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcomeMaria G Detsika, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Life (Basel, Switzerland)|September 23, 2022
C3a and C5b-9 Differentially Predict COVID-19 Progression and OutcomeMaria G Detsika, Elpida Diamanti, Kleio Ampelakiotou, et al.
Journal of Personalized Medicine|July 2, 2021
Antibody Response Following a Two-Dose mRNA Vaccination Regimen, in Health Care Workers of a Tertiary Hospital in Athens, GreeceElissavet Kontou, Kyriaki Ranellou, Dimitrios Zoulas, et al.
Endocrine Connections|May 19, 2021
Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infectionDimitra Argyro Vassiliadi, Ioannis Ilias, Maria Pratikaki, et al.
Research Square|January 9, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte ActivationJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
Research Square|July 3, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced ProtectionJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomolecules|May 4, 2026
The Complement System in the Setting of Critical Illness-A Narrative ReviewKleio Ampelakiotou, Ioanna Nikitopoulou, Stelios Kokkoris, et al.
Biomedicines|August 29, 2024
Erythropoietin Effect on Complement Activation in Chronic Kidney DiseaseVirginia Athanasiadou, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Virology|February 7, 2021
A novel ratio of CD8<sup>+</sup>:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcomeMaria G Detsika, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Life (Basel, Switzerland)|September 23, 2022
C3a and C5b-9 Differentially Predict COVID-19 Progression and OutcomeMaria G Detsika, Elpida Diamanti, Kleio Ampelakiotou, et al.
Journal of Personalized Medicine|July 2, 2021
Antibody Response Following a Two-Dose mRNA Vaccination Regimen, in Health Care Workers of a Tertiary Hospital in Athens, GreeceElissavet Kontou, Kyriaki Ranellou, Dimitrios Zoulas, et al.
Endocrine Connections|May 19, 2021
Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infectionDimitra Argyro Vassiliadi, Ioannis Ilias, Maria Pratikaki, et al.
Research Square|January 9, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte ActivationJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
Research Square|July 3, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced ProtectionJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
Pageof 1